Mike Erice was shocked when a biopsy determined that he was one of the more than 220,000 men diagnosed with prostate cancer each year. Just a year earlier, results of his annual prostate specific antigen test (PSA) had been excellent, giving the 60-year-old private investigator a sense of security.
This time, however, his doctor included a digital rectal exam and ordered the biopsy when he felt something suspicious. Because prostate cancer kills 28,000 men each year, Erice and his wife quickly researched their options, which included radiation therapy, watchful waiting and radical prostatectomy - major surgery to remove of the cancerous gland.
"If you have cancer, you just want it out. That is how I felt," he said. "I just didnt like the idea of major surgery that was painful and would keep me off the job for six weeks."
Therefore, when they found out about a minimally invasive surgical procedure that removes the gland through small incisions with less pain, fewer days in the hospital and quicker recovery, they came to the Cedars-Sinai Medical Center Endourology Institute, one of about 50 centers nationwide offering the new approach.
"Using minimally invasive techniques to treat prostate cancer became a natural extension of my previous experience in laparoscopic surgery in other areas of urology," said Gerhard Fuchs, M.D., director of the Institute and one of the worlds pioneers in endourology. "This application was adapted and improved over time and became a viable option for men about five years ago."
Endourologists use scopes and instruments to perform surgical procedures on organs and structures accessible through the urinary tract, without making an incision in a patients skin. In situations that do not permit the use of endourologic procedures, the least invasive approach - such as laparoscopic techniques that are accomplished with thin instruments inserted through tiny incisions - are employed. Dr. Fuchs has more than 20 years of experience in this specialty field.
The use of a laparoscope - a lighted tube with a tiny camera lens at the tip - provides a clear, magnified view of the prostate and surrounding nerves, resulting in greater precision, minimal blood loss, and greatly reduced risk of complications such as impairment of urinary continence and erectile function.
"An internal structure that the surgeon sees clearly can be better saved from damage during a procedure," explained Dr. Fuchs, noting that he expects his patients to maintain functions that are considered essential to quality of life. At least 95 percent of them are fully continent within a year of surgery, for example.
Like most of Dr. Fuchs patients undergoing laparoscopic prostatectomy, Mike Erice was out of the hospital in two days, experienced little pain, and said he felt almost like normal within five days. His body continues to function as it did before surgery. "I went back to work after 12 days and was very pleased that my life could continue almost without interruption," he said. He also recommended Dr. Fuchs and the Endourology Institute to a friend who was recently diagnosed with prostate cancer.
The PSA test, which measures a protein in the bloodstream produced by the cells of the prostate gland, is considered a fairly reliable indicator of the likelihood of prostate cancer, but Erice feels fortunate his physician was thorough.
"Dont rely on your PSA results alone," he said. "Get a digital rectal exam because you want to be sure. I am living proof that prostate cancer can hit any man and surgery today is not what it used to be."
Cedars-Sinai is one of the largest nonprofit academic medical centers in the Western United States. For the fifth straight two-year period, it has been named Southern Californias gold standard in health care in an independent survey. Cedars-Sinai is internationally renowned for its diagnostic and treatment capabilities and its broad spectrum of programs and services, as well as breakthroughs in biomedical research and superlative medical education. It ranks among the top 10 non-university hospitals in the nation for its research activities.
Sandra Van | Van Communications
Hepatitis: liver failure attributable to compromised blood supply
19.12.2018 | Technische Universität München
Collagen nanofibrils in mammalian tissues get stronger with exercise
14.12.2018 | University of Illinois College of Engineering
Different eras of civilization are defined by the discovery of new materials, as new materials drive new capabilities. And yet, identifying the best material...
Researchers from the University of Basel have reported a new method that allows the physical state of just a few atoms or molecules within a network to be controlled. It is based on the spontaneous self-organization of molecules into extensive networks with pores about one nanometer in size. In the journal ‘small’, the physicists reported on their investigations, which could be of particular importance for the development of new storage devices.
Around the world, researchers are attempting to shrink data storage devices to achieve as large a storage capacity in as small a space as possible. In almost...
The more objects we make "smart," from watches to entire buildings, the greater the need for these devices to store and retrieve massive amounts of data quickly without consuming too much power.
Millions of new memory cells could be part of a computer chip and provide that speed and energy savings, thanks to the discovery of a previously unobserved...
What if, instead of turning up the thermostat, you could warm up with high-tech, flexible patches sewn into your clothes - while significantly reducing your...
A widely used diabetes medication combined with an antihypertensive drug specifically inhibits tumor growth – this was discovered by researchers from the University of Basel’s Biozentrum two years ago. In a follow-up study, recently published in “Cell Reports”, the scientists report that this drug cocktail induces cancer cell death by switching off their energy supply.
The widely used anti-diabetes drug metformin not only reduces blood sugar but also has an anti-cancer effect. However, the metformin dose commonly used in the...
12.12.2018 | Event News
10.12.2018 | Event News
06.12.2018 | Event News
19.12.2018 | Information Technology
19.12.2018 | Physics and Astronomy
19.12.2018 | Life Sciences